Another study corroborated the epigenetic regulation of NRF2 by luteolin and showed reduced DNA methylation of the NFE2L2 promoter in luteolin-treated human colon adenocarcinoma HT29 cells. This evidence concerns the gene NFE2L2 and colon adenocarcinoma.